Valuation: Abbott Laboratories

Market Cap 178B 159B 147B 134B 253B 16,935B 257B 1,769B 693B 8,807B 668B 654B 28,150B P/E 2026 *
30.9x
P/E 2027 * 23.9x
Enterprise Value 202B 180B 167B 152B 287B 19,210B 292B 2,007B 786B 9,990B 758B 742B 31,932B EV / Sales 2026 *
4.03x
EV / Sales 2027 * 3.65x
Free-Float
86.16%
Yield 2026 *
2.46%
Yield 2027 * 2.62%
1 day+2.29%
1 week+6.03%
Current month+5.92%
1 month+1.54%
3 months+17.67%
6 months+3.59%
Current year-16.45%
1 week 98.2
Extreme 98.2
105.46
1 month 95.06
Extreme 95.06
105.46
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
132.02
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
30/09/26 Free

Director

333 0.0000%
30/09/26 Free

Director

318 0.0000%
30/09/26 Free

Director

381 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+2.29%+6.03%-21.45%+15.20% 178B
+1.29%+11.62%-1.13%+32.64% 121B
+4.12%+6.47%-20.75%+13.71% 108B
+0.41%+1.40%-45.37%-9.38% 75.7B
+1.56%+7.62%+7.39%+80.66% 64.15B
-1.75%-0.72%+17.66%+59.66% 53.49B
+2.58%+7.55%+2.87%-25.10% 51.45B
+3.43%+8.00%-14.09%+28.39% 41.68B
+5.08%+4.05%+32.47%+15.12% 31.5B
+1.78%+3.16% - - 31.52B
Average +2.08%+3.28%-4.71%+23.43% 75.62B
Weighted average by Cap. +2.03%+4.09%-10.53%+22.28%

Financials

2026 *2027 *
Net sales 50.2B 44.75B 41.5B 37.81B 71.19B 4,771B 72.52B 499B 195B 2,481B 188B 184B 7,931B 54.53B 48.61B 45.08B 41.07B 77.33B 5,182B 78.78B 542B 212B 2,695B 205B 200B 8,614B
Net income 6.16B 5.49B 5.09B 4.64B 8.74B 586B 8.9B 61.2B 23.97B 305B 23.12B 22.64B 974B 7.84B 6.99B 6.48B 5.91B 11.12B 745B 11.33B 77.89B 30.51B 388B 29.42B 28.81B 1,239B
Net Debt 23.94B 21.34B 19.79B 18.03B 33.95B 2,275B 34.59B 238B 93.12B 1,183B 89.81B 87.92B 3,782B 20.96B 18.68B 17.33B 15.79B 29.72B 1,992B 30.28B 208B 81.52B 1,036B 78.62B 76.97B 3,311B
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
15/10/26 $104.68 +1.66% 11,086,854
14/10/26 $102.97 +0.35% 7,286,701
13/10/26 $102.61 +0.78% 9,864,564
12/10/26 $101.82 +2.23% 7,147,039
09/10/26 $99.60 +1.13% 6,962,016
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
102.97USD
Average target price
120.72USD
Spread / Average Target
+17.23%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott Laboratories